Clinical trials recruiting for HIV Prevention

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
  NCT06703060 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
  NCT06745947 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 34 Years · Sex: All (male and female) · 1 location
• California MEPS Hub
  NCT07433985 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 59 Years · Sex: Male · 3 locations
• Dat'Aids Prevention
  NCT03795376 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 31 locations
• Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
  NCT07218211 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
  NCT07292584 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 4 locations
• Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
  NCT07349758 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
  NCT06493357 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years and older · Sex: All (male and female) · 3 locations
• Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)
  NCT07509827 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 29 Years · Sex: Male · 3 locations
• Feasibility of Internet-based HIV Prevention Research
  NCT07625917 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots
  NCT04979728 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• HIV Self-testing for Partners of HIV-uninfected Postpartum Women
  NCT07194902 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
  NCT07512869 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand
  NCT07509853 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intervention to Enhance PrEP Persistence
  NCT06872307 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 3 locations
• Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi
  NCT06506188 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 99 Years · Sex: All (male and female) · 1 location
• Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
  NCT07467018 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico
  NCT05804461 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 99 Years · Sex: Male · 1 location
• PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
  NCT07683117 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
  NCT06485154 · Phase: Phase 4 · Ages: 15 Years and older · Sex: All (male and female) · 3 locations
• PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
  NCT07231640 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
  NCT07505875 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health
  NCT07011563 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 17 Years · Sex: Male · 1 location
• RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
  NCT07136363 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stick2PrEP Cisgender Women and Trans Individuals
  NCT05165745 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
  NCT07002866 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 24 Years · Sex: Female · 2 locations
• Testing a Gender-inclusive HIV Prevention Program
  NCT06586151 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 18 Years · Sex: Male · 1 location
• The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
  NCT07512856 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
  NCT07292792 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
  NCT06158126 · Phase: Phase 4 · Ages: 15 Years to 55 Years · Sex: Female · 1 location
• Using PrEP, Doing It for Ourselves
  NCT06638892 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
  NCT06656676 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: Male · 1 location

Related conditions

Trials recruiting for HIV Prevention often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for HIV Prevention trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.